Framingham stroke risk function in a large population-based cohort of elderly people: The 3C study

Stroke

Volumn 40, Issue 5, 2009, Pages 1564-1570

  Bineau, Sébastien ^a,b   Dufouil, Carole ^a,b   Helmer, Catherine ^a   Ritchie, Karen ^a   Empana, Jean Philippe ^a   Ducimetière, Pierre ^c   Alpérovitch, Annick ^a,b   Bousser, Marie Germaine ^c   Tzourio, Christophe ^a,b,d  

^a INSERM   (France)

^b SORBONNE UNIVERSITÉ   (France)

^c HÔPITAL LARIBOISIÈRE   (France)

^d PITIÉ SALPÊTRIÈRE HOSPITAL   (France)

Author keywords

Aging; Cohort studies; Risk; Stroke

Indexed keywords

AGED; ARTICLE; CONTROLLED STUDY; EXTERNAL VALIDITY; FEMALE; FOLLOW UP; HUMAN; MAJOR CLINICAL STUDY; MALE; MEDICAL ASSESSMENT; MORBIDITY; PREVALENCE; PRIORITY JOURNAL; RISK FACTOR; STROKE; AGE; CALIBRATION; COHORT ANALYSIS; FRANCE; PHYSIOLOGY; POPULATION; PROPORTIONAL HAZARDS MODEL; REPRODUCIBILITY; RISK ASSESSMENT; ROC CURVE; SEX DIFFERENCE; STATISTICAL ANALYSIS;

AGE FACTORS; AGED; AGED, 80 AND OVER; CALIBRATION; COHORT STUDIES; DATA INTERPRETATION, STATISTICAL; FEMALE; FRANCE; HUMANS; MALE; POPULATION; PROPORTIONAL HAZARDS MODELS; REPRODUCIBILITY OF RESULTS; RISK ASSESSMENT; RISK FACTORS; ROC CURVE; SEX FACTORS; STROKE;

EID: 65549093984     PISSN: 00392499     EISSN: None     Source Type: Journal    
DOI: 10.1161/STROKEAHA.108.532325     Document Type: Article

References (28)

1. Lopez AD, Mathers CD, Ezzati M, Jamison DT, Murray CJ. Global and regional burden of disease and risk factors, 2001: systematic analysis of population health data. Lancet. 2006;367:1747-1757.
2. BonitaR. Epidemiology of stroke. Lancet. 1992;339:342-344.
3. Wolf PA. Risk factors for stroke. Stroke. 1985;16:359-360.
4. Manolio TA, Kronmal RA, Burke GL, O'Leary DH, Price TR. Short-term predictors of incident stroke in older adults. The Cardiovascular Health Study. Stroke. 1996;27:1479-1486.
5. Anderson KM, Odell PM, Wilson PW, Kannel WB. Cardiovascular disease risk profiles. Am Heart J. 1991;121:293-298.
6. D'Agostino RB, Wolf PA, Belanger AJ, Kannel WB. Stroke risk profile: adjustment for antihypertensive medication. The Framingham Study. Stroke. 1994;25:40-43.
7. Lumley T, Kronmal RA, Cushman M, Manolio TA, Goldstein S. A stroke prediction score in the elderly: validation and Web-based application. J Clin Epidemiol. 2002;55:129-136.
8. Tanne D, Yaari S, Goldbourt U. Risk profile and prediction of long-term ischemic stroke mortality: a 21-year follow-up in the Israeli Ischemic Heart Disease (IIHD) Project. Circulation. 1998;98:1365-1371.
9. Wolf PA, D'Agostino RB, Belanger AJ, Kannel WB. Probability of stroke: a risk profile from the Framingham Study. Stroke. 1991;22: 312-318.
10. Bastuji-Garin S, Deverly A, Moyse D, Castaigne A, Mancia G, de Leeuw PW, Ruilope LM, Rosenthal T, Chatellier, G. The Framingham prediction rule is not valid in a European population of treated hypertensive patients. J Hypertens. 2002;20:1973-1980.
11. Voko Z, Hollander M, Koudstaal PJ, Hofman A, Breteler MM. How do Am stroke risk functions perform in a Western European population? Neuroepidemiology. 2004;23:247-253.
12. The 3C Study Group. Vascular factors and risk of dementia: design of the Three-City Study and baseline characteristics of the study population. Neuroepidemiology. 2003;22:316-325.
13. http://www.theriaque.org. Centre National Hospitalier d'Information sur le Medicament, France 2002.
14. Report of the Expert Committee on the Diagnosis and Classification of Diabetes Mellitus. Diabetes Care. 1997;20:1183-1197.
15. World Health Organization. International Statistical Classification of Diseases and Related Health Problems, Tenth Revision (ICD-10). Geneva, Switzerland: World Health Organization, 1992.
16. Cox DR. Regression Models and Life-Tables (with Discussion). J R Stat Soc B. 1972;34:187-220.
17. D'Agostino RB Sr, Grundy S, Sullivan LM, Wilson P. Validation of the Framingham coronary heart disease prediction scores: results of a multiple ethnic groups investigation. JAMA. 2001;286:180-187.
18. Little RJA, Rubin DB. Statistical Analysis with Missing Data. I ed. New York: John Wiley & Sons Inc; 1987.
19. Liu J, Hong YL, D'Agostino RB, Wu ZS, Wang W, Sun JY, Wilson PWF, Kannel WB, Zhao D. Predictive value for the Chinese population of the Framingham CHD risk assessment tool compared with the Chinese multi-provincial cohort study. JAMA. 2004;291:2591-2599.
20. Hosmer D, Lemeshow SA goodness-of-fit test for the multiple logistic regression model. Comm Stat. 1980;A10:1043-1069.
21. D'Agostino R, Nam BH. Evaluation of the performance of survival analysis model: discrimination and calibration measures. Handbook of Statistics, Vol. 23. Amsterdam, The Netherlands: Elsevier; 2004:1-25.
22. Empana JP, Ducimetiere P, Arveiler D, Ferrieres J, Evans A, Amouyel PH, Dalongeville J. Are the Framingham and PROCAM coronary heart disease risk functions applicable to different European populations? The PRIME Study. Eur Heart J. 2003;24:299.
23. Rothman KJ, Greenland S. Modern Epidemiology. II ed. Lippincott-Raven Publishers; 1998.
24. Hosmer D, Lemeshow S. Applied Logistic Regression. II ed. New York: John Wiley & Sons Inc; 2000.
25. Carandang R, Seshadri S, Beiser A, Kelly-Hayes M, Kase CS, Kannel WB, Wolf PA. Trends in incidence, lifetime risk, severity, and 30-day mortality of stroke over the past 50 years. JAMA. 2006;296: 2939-2946.
26. Bots ML, Elwood PC, Nikitin Y, Salonen JT, Freire dC, Inzitari D et al. Total and HDL cholesterol and risk of stroke. EUROSTROKE: a collaborative study among research centres in Europe. J Epidemiol Community Health. 2002;56:i19-i24.
27. Touboul PJ, Labreuche J, Vicaut E, Amarenco P. Carotid intima-media thickness, plaques, and Framingham risk score as independent determinants of stroke risk. Stroke. 2005;36:1741-1745.
28. Jeerakathil T, Wolf PA, Beiser A, Massaro J, Seshadri S, D'Agostino RB, Sivenius J, Benetou V, Tuomilehto J, Koudstaal PJ, Grobbee DE. Stroke risk profile predicts white matter hyperintensity volume: the Framingham Study. Stroke. 2004;35:1857-1861.